Anticancer therapy with HDAC inhibitors: mechanism-based combination strategies and future perspectives

R Jenke, N Reßing, FK Hansen, A Aigner, T Büch - Cancers, 2021 - mdpi.com
Simple Summary Beyond mutations, epigenetic changes have been described as drivers for
cancer as well. While leaving the overall DNA structure intact, they can be responsible for …

Epigenetics in cancer stem cells

TB Toh, JJ Lim, EKH Chow - Molecular cancer, 2017 - Springer
Compelling evidence have demonstrated that bulk tumors can arise from a unique subset of
cells commonly termed “cancer stem cells” that has been proposed to be a strong driving …

Signaling pathways in cancer metabolism: mechanisms and therapeutic targets

M You, Z Xie, N Zhang, Y Zhang, D Xiao, S Liu… - … and Targeted Therapy, 2023 - nature.com
A wide spectrum of metabolites (mainly, the three major nutrients and their derivatives) can
be sensed by specific sensors, then trigger a series of signal transduction pathways and …

Epigenetics of breast cancer: Biology and clinical implication in the era of precision medicine

B Pasculli, R Barbano, P Parrella - Seminars in cancer biology, 2018 - Elsevier
In the last years, mortality from breast cancer has declined in western countries as a
consequence of a more widespread screening resulting in earlier detection, as well as an …

Epigenetic therapy of cancer with histone deacetylase inhibitors

KC Lakshmaiah, LA Jacob, S Aparna… - Journal of cancer …, 2014 - journals.lww.com
Epigenetics is the study of heritable alterations in gene expression that are not accompanied
by the corresponding change in DNA sequence. Three interlinked epigenetic processes …

Epigenetic treatment of solid tumours: a review of clinical trials

C Nervi, E De Marinis, G Codacci-Pisanelli - Clinical epigenetics, 2015 - Springer
Epigenetic treatment has been approved by regulatory agencies for haematological
malignancies. The success observed in cutaneous lymphomas represents a proof of …

Vorinostat (SAHA) and breast cancer: an overview

A Wawruszak, L Borkiewicz, E Okon, W Kukula-Koch… - Cancers, 2021 - mdpi.com
Simple Summary Breast cancer (BC) is the most frequent malignancy diagnosed in 2020
worldwide. Despite significant advances in BC therapy, its pathogenesis is still not fully …

Harnessing epigenetics for breast cancer therapy: The role of DNA methylation, histone modifications, and MicroRNA

J Szczepanek, M Skorupa, J Jarkiewicz-Tretyn… - International Journal of …, 2023 - mdpi.com
Breast cancer exhibits various epigenetic abnormalities that regulate gene expression and
contribute to tumor characteristics. Epigenetic alterations play a significant role in cancer …

Drug repositioning with adaptive graph convolutional networks

X Sun, X Jia, Z Lu, J Tang, M Li - Bioinformatics, 2024 - academic.oup.com
Motivation Drug repositioning is an effective strategy to identify new indications for existing
drugs, providing the quickest possible transition from bench to bedside. With the rapid …

Emerging role of histone deacetylase inhibitors as anti-breast-cancer agents

MK Ediriweera, KH Tennekoon, SR Samarakoon - Drug discovery today, 2019 - Elsevier
Highlights•Breast cancer is the most frequently diagnosed cancer in women.•Aberrant
expression of HATs and HDACs has been reported in breast cancer.•Epigenetic therapy is …